NaliniMRajamannanMD

Non-Invasive Cardiology

Dr. Nalini Rajamannan is a heart valve expert in the field of cardiovascular medicine. She has been researching heart valve disease for 31 years. She earned her undergraduate science pre-professional degree from the University of Notre Dame, her Medical Doctorate from Mayo Medical School and her post-graduate training in Internal Medicine and Cardiology at the Mayo Clinic.

Join to view full profile

Dr. Rajamannan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rajamannan's full profile

Already have an account?

Office
Sacred Cardiology
Chicago, IL 60611
Fax+1 855-827-3381
Is this information wrong?

Summary

https://www.youtube.com/watch?v=X00NFQJqQHI&t=54s

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1994 - 2000
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
Mayo Clinic College of MedicineClass of 1989

Certifications & Licensure

IL State Medical License 2000 - 2026
WI State Medical License 1999 - 2025
MN State Medical License 1990 - 2024
FL State Medical License 1990 - 1998
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Rosuvastatin Affecting Aortic Valve Endothelium Start of enrollment: 2003 Sep 01
Completed

Publications & Presentations

PubMed

The Lp(a)/BMI Gradient in Osteocardiology: The Copenhagen Connection.
Nalini M Rajamannan> ;Journal of the American College of Cardiology. 2022 Feb 15
3 citations
Bench to bedside defining calcific aortic valve disease: osteocardiology.
Nalini M. Rajamannan, Luis M Moura, Patricia J.M. Best> ;Expert Review of Cardiovascular Therapy. 2020 May 12
2 citations
TIEG1 is upregulated in Lrp5/6‐mediated valve osteogenesis
Nalini M. Rajamannan> ;Journal of Cellular Biochemistry. 2019 Mar 1
2 citations
Fenfluramine-Phentermine is Associated with an Increase in Cellular Proliferation Ex Vivo and In Vitro.
Nalini M. Rajamannan> ;The Journal of Heart Valve Disease. 2017 Jul 1
6 citations
Osteocardiology: Defining the Go/No-Go Time Point for Therapy.
Nalini M. Rajamannan> ;Cardiology. 2018 Jan 1
24 citations
Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study)
Anders M. Greve, Casper N. Bang, Kurt Boman, Kenneth Egstrup, Julie Lyng Forman, Y. Antero Kesäniemi, Simon Ray, Terje R. Pedersen, Patricia J.M. Best, Nalini M. Rajam...> ;The American Journal of Cardiology. 2017 Dec 25
1 citations
Aortic Valve Disease Is Not a Monogenetic Disorder.
Nalini M. Rajamannan> ;JACC. Basic to Translational Science. 2017 Oct 1
1 citations
OxPL: Elusive Risk Factor in Calcific Aortic Valve Disease or Another Piece of the Puzzle?
Patricia J.M. Best, Nalini M. Rajamannan> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2017 Aug 1
17 citations
TIEG1 modulates β-catenin sub-cellular localization and enhances Wnt signaling in bone.
Malayannan Subramaniam, Muzaffer Cicek, Kevin S. Pitel, Elizabeth S. Bruinsma, Molly Nelson Holte, Sarah G. Withers, Nalini M. Rajamannan, Frank J. Secreto, K. Venupra...> ;Nucleic Acids Research. 2017 May 19
4 citations
Aortic Vascular Calcification: Cholesterol Lowering Does Not Reduce Progression in Patients With Familial Hypercholesterolemia-or Does It?
Nalini M. Rajamannan, Stanley Nattel> ;The Canadian Journal of Cardiology. 2017 May 1
6 citations
The Lipid Hypothesis in Calcific Aortic Valve Disease: The Role of the Multi-Ethnic Study of Atherosclerosis.
Nalini M. Rajamannan, Luis M Moura> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2016 May 1
2 citations
Role of Oxidative Stress Markers in Left-Sided Valve Disease: The LDL-Density-Pressure Theory.
Nalini M. Rajamannan> ;Cardiology. 2016 Jan 1
4 citations
Calcific Aortic Valve Disease in Familial Hypercholesterolemia: The LDL-Density-Gene Effect.
Nalini M. Rajamannan> ;Journal of the American College of Cardiology. 2015 Dec 22
8 citations
SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory
Nalini M. Rajamannan, Anders M. Greve, Luis M Moura, Patricia J.M. Best, Kristian Wachtell> ;Expert Review of Cardiovascular Therapy. 2015 Mar 21
13 citations
Atorvastatin Attenuates Bone Loss and Aortic Valve Atheroma in LDLR Mice.
Nalini M. Rajamannan> ;Cardiology. 2015 Jan 1
1 citations
Embryonic cell origin defines functional role of Lrp5.
Nalini M. Rajamannan> ;Atherosclerosis. 2014 Sep 1
2 citations
Valvuloplasty with a paclitaxel-eluting balloon prevents restenosis in an experimental animal model of aortic stenosis.
Konstantinos Spargias, Mariann Gyöngyösi, Rayyan Hemetsberger, Anikó Pósa, Noemi Pavo, Imre Pavo, Kurt Huber, Zsolt Petrasi, Örs Petneházy, Rembert Pogge von Strandman...> ;The Journal of Heart Valve Disease. 2014 Jul 1
51 citations
Bicuspid aortic valve hemodynamics induces abnormal medial remodeling in the convexity of porcine ascending aortas.
Samantha K. Atkins, Kai Cao, Nalini M. Rajamannan, Philippe Sucosky> ;Biomechanics and Modeling in Mechanobiology. 2014 Mar 6
8 citations
Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.
Nalini M. Rajamannan> ;Expert Review of Cardiovascular Therapy. 2014 Feb 27
58 citations
Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.
Ling Sun, Nalini M. Rajamannan, Philippe Sucosky> ;Plos One. 2013 Dec 23
1 citations
The risk of infective endocarditis in the 21st century.
Nalini M. Rajamannan> ;Indian Heart Journal. 2013 Jul 1
11 citations
Aortic sclerosis and mitral annulus calcification: a window to vascular atherosclerosis?
George Lazaros, Konstantinos Toutouzas, Maria Drakopoulou, Harisios Boudoulas, Christodoulos Stefanadis, Nalini M. Rajamannan> ;Expert Review of Cardiovascular Therapy. 2013 Jul 1
23 citations
Serum phosphate and hip bone mineral density as additional factors for high vascular calcification scores in a community-dwelling: The Sao Paulo Ageing & Health Study ...
Camille P. Figueiredo, Nalini M. Rajamannan, Jaqueline B. Lopes, Valeria F. Caparbo, Liliam Takayama, Marcia E. Kuroishi, Ilka S. Oliveira, Paulo Rossi Menezes, Marcia...> ;Bone. 2013 Jan 1
4 citations
Progression of aortic valve stenosis in adults: A systematic review
Helena J. Heuvelman, Martijn W.A. van Geldorp, Marinus J.C. Eijkemans, Nalini M. Rajamannan, Ad J.J.C. Bogers, Jolien W. Roos-Hesselink, Johanna J.M. Takkenberg> ;The Journal of Heart Valve Disease. 2012 Jul 1
22 citations
TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy.
J. Martijn Bos, Malayannan Subramaniam, John R. Hawse, Imke Christiaans, Nalini M. Rajamannan, Joseph J. Maleszewski, William D. Edwards, Arthur A.M. Wilde, Thomas C. ...> ;Journal of Cellular Biochemistry. 2012 Jun 1
Join now to see all

Press Mentions

Dr. Nalini Rajamannan's Publishes Her New Book: The Final FDA Revelations, a Victory for U.S. Citizens Available on Barnes and Nobel March 14, 2022March 14th, 2022
Vaccine Disparities: Who Is Choosing Not to Get the Shot in Wisconsin, and WhyJune 11th, 2021
Doctor: Faulty Device Implanted in Hundreds of Patients Without ConsentMarch 10th, 2020
Join now to see all